Status:
TERMINATED
Feasibility of At-Home Handheld Spirometry
Lead Sponsor:
University of Chicago
Conditions:
COPD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators' central hypotheses predict that the handheld spirometry device will be feasible for inpatient and at-home use, and is equally efficacious at determining lung function when compared ...
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) results in nearly 750,000 hospitalizations annually and is the third leading cause of "early" (within 30-day) hospital readmissions in the United States. C...
Eligibility Criteria
Inclusion
- 18+ years
- Physician-diagnosed COPD
- Able to perform spirometry
- Access to wireless internet at home
- Visual acuity of at least 20/50 in one eye
Exclusion
- Currently in ICU
- Physician declines to provide consent
- Patient unable to provide consent or declines to provide consent
Key Trial Info
Start Date :
September 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03284203
Start Date
September 30 2017
End Date
March 1 2018
Last Update
May 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medicine
Chicago, Illinois, United States, 60637